🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT03313024
Recruiting Observational

Berlin-Brandenburg Pregnancy Cohort

NCT03313024 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2017-09-26
Last updated
2018-08-14

Condition(s) studied

PreeclampsiaPregnancy ComplicationsDiabetes Mellitus in Pregnancy

Study summary

This study will investigate the interplay of different immune cells and placental cells as well as their potential for the development of pregnancy complications. In particular, the translation of the uteroplacental syndrome into a maternal syndrome, considered in the multifactorial pregnancy disorder preeclampsia, will be investigated. Immune cell subtypes are causally involved in the formation and translation of preeclampsia by inducing an endothelial dysfunction which leads to cardiovascular damage.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * healthy pregnant women after giving informed consent * pregnant with diagnosis of preeclampsia, gestational hypertension or gestational diabetes Exclusion Criteria: * infections * alcohol and drug abuse * manifest and chronic diseases

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Experimental and Clinical Research Center (ECRC) Berlin Germany Recruiting

More Charite University, Berlin, Germany trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03313024 on ClinicalTrials.gov ↗ ← All trials in Germany